Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1

Conditions

Pancreatic Neoplasms 18Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasms 5Neoplasm Metastasis 5Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma 2Vaccinia 1Uterine Cervical Neoplasms 1Squamous Non-small Cell Lung Cancer 1Rectal Neoplasms 1Pathologic Complete Response 1Pancreatic Ductal Adenocarcinoma 1Neoplasms by Site 1Neoplasms by Histologic Type 1Melanoma 1Locally Advanced Pancreatic Cancer 1Gastric Adenocarcinoma 1Gallbladder Cancer Unresectable 1Diabetes Mellitus, Insulin-Dependent, 12 1Colonic Neoplasms 1Carcinoma, Pancreatic Ductal 1Brain Neoplasms 1Anal Cancer Metastatic 1

Interventions

pembrolizumab 20Bevacizumab 14Carboplatin 12Standard of Care 10Nivolumab 9Cyclophosphamide 9Cetuximab 8Pemetrexed 7Exercise 7Doxorubicin 7durvalumab 6atezolizumab 6Temozolomide 6Radiotherapy 6Prednisone 6Paclitaxel 6Cisplatin 6Blood Specimen Collection 6abemaciclib 5Fluorouracil 5130-nm albumin-bound paclitaxel 5olaparib 4dostarlimab 4Rituximab 4Leucovorin 4Gemcitabine 4Fulvestrant 4Docetaxel 4Dexamethasone 4venetoclax 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasms × 130-nm albumin-bound paclitaxel × 30 days × Clear all
NCT06463665 2026-06-04

VIRO-25

Genelux Corporation

Phase 2 Recruiting
142 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Vaccinia

NCT06360354 2026-06-01

MTAPESTRY 103

Amgen

Phase 1 Active not recruiting
120 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT03530397 2026-05-19

A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors

MedImmune LLC

Phase 1 Active not recruiting
400 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Neoplasms

NCT06119217 2026-05-13

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Trishula Therapeutics, Inc.

Phase 2 Completed
194 enrolled 16 charts
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT07578337 2026-05-13

NUMANTIA-2

Nelum Corp

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡